ADVANCED TECHNOLOGIES AND REGE has a total of 14 patent applications. Its first patent ever was published in 2008. It filed its patents most often in China, Canada and EPO (European Patent Office). Its main competitors in its focus markets medical technology and pharmaceuticals are HANS BIOMED COR, GRAFTYS and MIMEDX GROUP INC.
# | Country | Total Patents | |
---|---|---|---|
#1 | China | 5 | |
#2 | Canada | 3 | |
#3 | EPO (European Patent Office) | 3 | |
#4 | WIPO (World Intellectual Property Organization) | 2 | |
#5 | United States | 1 |
# | Industry | |
---|---|---|
#1 | Medical technology | |
#2 | Pharmaceuticals |
# | Technology | |
---|---|---|
#1 | Object sterilising | |
#2 | Medical preparations | |
#3 | Therapeutic chemical compounds | |
#4 | Implantable devices | |
#5 | Diagnosis and surgery |
# | Name | Total Patents |
---|---|---|
#1 | Shetty Dhanuraj | 6 |
#2 | Dhanaraj Sridevi | 6 |
#3 | Wang Ziwei | 5 |
#4 | Hammer Joseph J | 4 |
#5 | Geesin Jeffrey C | 3 |
#6 | Dongling Su | 3 |
#7 | Sen Asok C | 2 |
#8 | Su Dongling | 2 |
#9 | Donners Jackie Jacobus Johannes Maria | 2 |
#10 | Julius Lopez | 2 |
Publication | Filing date | Title |
---|---|---|
CN102026619A | Liquid buffered GDF-5 formulations | |
US2009246247A1 | Composite enterocystoplasty | |
EP2070491A2 | Optimum density fibrous matrix | |
CN101801405A | Be contained in the protein formulations of the GDF-5 in the acidic aqueous solution | |
CN101801404A | Protein formulations for use at elevated temperatures | |
EP2150284A2 | Tissue engineering devices and methods for luminal organs |